Literature DB >> 22553399

Pro-apoptotic effects of tectorigenin on human hepatocellular carcinoma HepG2 cells.

Chun-Ping Jiang1, Hui Ding, Da-Hua Shi, Yu-Rong Wang, Er-Guang Li, Jun-Hua Wu.   

Abstract

AIM: To investigate the effects of tectorigenin on human hepatocellular carcinoma (HCC) HepG2 cells.
METHODS: Tectorigenin, one of the main components of rhizome of Iris tectorum, was prepared by simple methods, such as extraction, filtration, concentration, precipitation and recrystallization. HepG2 cells were incubated with tectorigenin at different concentrations, and their viability was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Apoptosis was detected by morphological observation of nuclear change, agarose gel electrophoresis of DNA ladder, and flow cytometry with Hoechst 33342, Annexin V-EGFP and propidium iodide staining. Generation of reactive oxygen species was quantified using DCFH-DA. Intracellular Ca(2+) was monitored by Fura 2-AM. Mitochondrial membrane potential was monitored using Rhodamine 123. Release of cytochrome c from mitochondria to cytosol was detected by Western blotting. Activities of caspase-3, -8 and -9 were investigated by Caspase Activity Assay Kit.
RESULTS: The viability of HepG2 cells treated by tectorigenin decreased in a concentration- and time-dependent manner. The concentration that reduced the number of viable HepG2 cells by 50% (IC(50)) after 12, 24 and 48 h of incubation was 35.72 mg/L, 21.19 mg/L and 11.06 mg/L, respectively. However, treatment with tectorigenin at 20 mg/L resulted in a very slight cytotoxicity to L02 cells after incubation for 12, 24 or 48 h. Tectorigenin at a concentration of 20 mg/L greatly inhibited the viability of HepG2 cells and induced the condensation of chromatin and fragmentation of nuclei. Tectorigenin induced apoptosis of HepG2 cells in a time- and dose-dependent manner. Compared with the viability rate, induction of apoptosis was the main mechanism of the anti-proliferation effect of tectorigenin in HepG2 cells. Furthermore, tectorigenin-induced apoptosis of HepG2 cells was associated with the generation of reactive oxygen species, increased intracellular [Ca(2+)](i), loss of mitochondrial membrane potential, translocation of cytochrome c, and activation of caspase-9 and -3.
CONCLUSION: Tectorigenin induces apoptosis of HepG2 cells mainly via mitochondrial-mediated pathway, and produces a slight cytotoxicity to L02 cells.

Entities:  

Keywords:  Apoptosis; HepG2; Hepatocellular carcinoma; Iris tectorum maxim; Liver cancer; Mitochondria; Tectorigenin

Mesh:

Substances:

Year:  2012        PMID: 22553399      PMCID: PMC3332288          DOI: 10.3748/wjg.v18.i15.1753

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  36 in total

1.  Early mitochondrial activation and cytochrome c up-regulation during apoptosis.

Authors:  Dhyan Chandra; Jun-Wei Liu; Dean G Tang
Journal:  J Biol Chem       Date:  2002-10-28       Impact factor: 5.157

Review 2.  Regulation of cell death: the calcium-apoptosis link.

Authors:  Sten Orrenius; Boris Zhivotovsky; Pierluigi Nicotera
Journal:  Nat Rev Mol Cell Biol       Date:  2003-07       Impact factor: 94.444

Review 3.  Calcium-mediated cell injury and cell death.

Authors:  B F Trump; I K Berezesky
Journal:  FASEB J       Date:  1995-02       Impact factor: 5.191

4.  Mechanisms of hydrogen peroxide-induced calcium dysregulation in PC12 cells.

Authors:  H Wang; J A Joseph
Journal:  Free Radic Biol Med       Date:  2000-04-15       Impact factor: 7.376

5.  Protective effect of hopeahainol A, a novel acetylcholinesterase inhibitor, on hydrogen peroxide-induced injury in PC12 cells.

Authors:  Da Hua Shi; Jun Hua Wu; Hui Ming Ge; Ren-Xiang Tan
Journal:  Environ Toxicol Pharmacol       Date:  2009-02-11       Impact factor: 4.860

6.  Passive cutaneous anaphylaxis-inhibitory action of tectorigenin, a metabolite of tectoridin by intestinal microflora.

Authors:  Eun-Kyung Park; Yong-Wook Shin; Hae-Ung Lee; Chang Soo Lee; Dong-Hyun Kim
Journal:  Biol Pharm Bull       Date:  2004-07       Impact factor: 2.233

7.  Troglitazone, a peroxisome proliferator-activated receptor gamma ligand, induces growth inhibition and apoptosis of HepG2 human liver cancer cells.

Authors:  Yan-Ming Zhou; Yin-Hao Wen; Xiao-Yan Kang; Hai-Hua Qian; Jia-Mei Yang; Zheng-Feng Yin
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

8.  Induction of apoptosis in human liver carcinoma HepG2 cell line by 5-allyl-7-gen-difluoromethylenechrysin.

Authors:  Xiang-Wen Tan; Hong Xia; Jin-Hua Xu; Jian-Guo Cao
Journal:  World J Gastroenterol       Date:  2009-05-14       Impact factor: 5.742

Review 9.  Death receptors as targets of cancer therapeutics.

Authors:  M Saeed Sheikh; Ying Huang
Journal:  Curr Cancer Drug Targets       Date:  2004-02       Impact factor: 3.428

10.  Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner.

Authors:  E A Slee; M T Harte; R M Kluck; B B Wolf; C A Casiano; D D Newmeyer; H G Wang; J C Reed; D W Nicholson; E S Alnemri; D R Green; S J Martin
Journal:  J Cell Biol       Date:  1999-01-25       Impact factor: 10.539

View more
  12 in total

1.  Excretion of tectorigenin in rat urine orally administrated at different dosages by ultra-performance liquid chromatography coupled to quadrupole time-of-flight mass spectrometry.

Authors:  Ziming Shi; Guozhe Zhang; Lizhu Zhao; Shen Wang; Yoshihiro Kano; Dan Yuan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-05-01       Impact factor: 2.441

2.  Mechanism of apoptosis induction in human hepatocellular carcinoma cells following treatment with a gecko peptides mixture.

Authors:  Ying Jin; Leng-Xin Duan; Xin-Li Xu; Wen-Jing Ge; Rui-Fang Li; Xiang-Jun Qiu; Ying Song; Shan-Shan Cao; Jian-Gang Wang
Journal:  Biomed Rep       Date:  2016-04-25

3.  Apoptotic effects of ε-viniferin in combination with cis-platin in C6 cells.

Authors:  Filiz Özdemir; Elif Apaydın; Nur İpek Önder; Mesut Şen; Aysun Ayrım; Yüksel Öğünç; Zerrin İncesu
Journal:  Cytotechnology       Date:  2018-02-23       Impact factor: 2.058

4.  The involvement of endoplasmic reticulum stress in bile acid-induced hepatocellular injury.

Authors:  Tetsuo Adachi; Tomoyuki Kaminaga; Hiroyuki Yasuda; Tetsuro Kamiya; Hirokazu Hara
Journal:  J Clin Biochem Nutr       Date:  2013-12-27       Impact factor: 3.114

Review 5.  Anticancer activities and mechanisms of heat-clearing and detoxicating traditional Chinese herbal medicine.

Authors:  Yulin Zhang; Yeer Liang; Chengwei He
Journal:  Chin Med       Date:  2017-07-12       Impact factor: 5.455

6.  Anti-proliferative effect of novel primary cetyl alcohol derived sophorolipids against human cervical cancer cells HeLa.

Authors:  Laxman Nawale; Parul Dubey; Bhushan Chaudhari; Dhiman Sarkar; Asmita Prabhune
Journal:  PLoS One       Date:  2017-04-18       Impact factor: 3.240

7.  Anti‑proliferative effect of honokiol on SW620 cells through upregulating BMP7 expression via the TGF‑β1/p53 signaling pathway.

Authors:  Qin Li; Yan Ma; Xiao-Lu Liu; Li Mu; Bai-Cheng He; Ke Wu; Wen-Juan Sun
Journal:  Oncol Rep       Date:  2020-08-28       Impact factor: 3.906

8.  Cratoxylum formosum (Jack) Dyer ssp. pruniflorum (Kurz) Gogel. (Hóng yá mù) extract induces apoptosis in human hepatocellular carcinoma HepG2 cells through caspase-dependent pathways.

Authors:  Apiyada Nonpunya; Natthida Weerapreeyakul; Sahapat Barusrux
Journal:  Chin Med       Date:  2014-04-07       Impact factor: 5.455

9.  Morusin shows potent antitumor activity for human hepatocellular carcinoma in vitro and in vivo through apoptosis induction and angiogenesis inhibition.

Authors:  Ling Gao; Li Wang; Zhen Sun; Haiyan Li; Qiaoping Wang; Cheng Yi; Xiujie Wang
Journal:  Drug Des Devel Ther       Date:  2017-06-16       Impact factor: 4.162

10.  Avicularin ameliorates human hepatocellular carcinoma via the regulation of NF‑κB/COX‑2/PPAR‑γ activities.

Authors:  Zhimin Wang; Fang Li; Yuan Quan; Junye Shen
Journal:  Mol Med Rep       Date:  2019-04-25       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.